insys

Showing 6 posts of 6 posts found.

shutterstock_92671375

Former Insys sales exec sentenced to a year in prison for offering lap dances to encourage fentanyl spray prescriptions

January 23, 2020
Medical Communications, Sales and Marketing insys, pharma

A sales executive at the disgraced and bankrupted firm Insys who was accused of offering lap dances in order to …

Insys Therapeutics files for bankruptcy

June 11, 2019
Manufacturing and Production DoJ, Subsys, bankruptcy, insys, pharma

Opioid drugmaker Insys Therapeutics has filed for Chapter 11 bankruptcy protection after agreeing to pay $225 million to settle charges …

top_10_image

Top Ten most popular articles on Pharmafile.com this week!

February 1, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, England, NHS, Purdue, Vertex, insys, israel, oncology, pharma, top 10

Scandal dominated this week’s news after Sunrise Lee, a stripper turned Insys sales rep was alleged to have given a …

Stripper-turned-Insys sales rep gave lap dance to persuade doctor to prescribe fentanyl

January 31, 2019
Medical Communications Sunrise Lee, US, chicago, corruption, insys, sales

A pharmaceutical executive working for Insys therapeutics has been accused of giving a doctor a lap dance in an effort …

Insys Therapeutics reaches $150m agreement to settle opioid marketing case

August 9, 2018
Medical Communications, Sales and Marketing Litigation, Subsys, US Department of Justice, fentanyl, insys, opioid, pharma

The Arizona-based pharma company Insys Therapeutics has reached an agreement to pay $150 million to the US Department of Justice …

US regulators FDA building

FDA rejects Insys Therapeutics sublingual opioid spray

July 31, 2018
Manufacturing and Production Crisis, FDA, insys, opioid, rejection, spray

The FDA has rejected Insys Therapeutics buprenorphine sublingual spray due to concerns about the safety of the Arizona-based company’s opioid …

Latest content